Astron Limited logo

Astron Limited (ATR)

Market Open
CXA CXA
- Market Cap
31.31 P/E Ratio
1.8% Div Yield
2,868 Volume
4.69 Eps
Want to track ATR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 59 days

Summary

ATR trading today lower, a decrease of 4% from yesterday's close, completing a monthly decrease of -12.2%. Over the past 12 months, ATR stock gained 24.14%.
ATR pays dividends to its shareholders, with the most recent payment made on Nov 13, 2025. The next estimated payment will be in In 2 months on Feb 13, 2026 for a total of A$0.48.
The last earnings report, released on Oct 30, 2025, exceeded the consensus estimates by 0.05%. On average, the company has surpassed earnings expectations by 0.05%, based on the last three reports. The next scheduled earnings report is due on Feb 05, 2026.
Astron Limited has completed 2 stock splits, with the recent split occurring on May 10, 2007.
The company's stock is traded on 9 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Is the Options Market Predicting a Spike in AptarGroup Stock?

Is the Options Market Predicting a Spike in AptarGroup Stock?

Investors need to pay close attention to ATR stock based on the movements in the options market lately.

Zacks | 4 days ago
AptarGroup, Inc. (ATR) Presents at Jefferies London Healthcare Conference 2025 Transcript

AptarGroup, Inc. (ATR) Presents at Jefferies London Healthcare Conference 2025 Transcript

AptarGroup, Inc. ( ATR ) Jefferies London Healthcare Conference 2025 November 19, 2025 7:00 AM EST Company Participants Stephan Tanda - President, CEO & Executive Director Gael Touya - President of Aptar Pharma Vanessa Kanu - Executive VP & CFO Conference Call Participants Daniel Rizzo - Jefferies LLC, Research Division Presentation Daniel Rizzo Jefferies LLC, Research Division Good afternoon. I am Dan Rizzo with Jefferies Equity Research.

Seekingalpha | 2 weeks ago
AptarGroup: Pharma Setback Creates Long-Term Opportunities

AptarGroup: Pharma Setback Creates Long-Term Opportunities

AptarGroup's shares have dropped over 25% from summer highs due to slower growth, especially in high-margin pharma emergency solutions. ATR's valuation has compressed from 26x to 20x earnings, reflecting concerns about flat growth and a soft outlook for 2026. Pharma remains the most profitable segment, but headwinds in emergency-use delivery systems are expected to impact revenues next year.

Seekingalpha | 1 month ago

Astron Limited (ATR) FAQ

On which exchange is it traded?

Astron Limited is listed on NYSE.

What is its stock symbol?

The ticker symbol is ATR.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.8%.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 1.29.

When is the next earnings date?

The next earnings report will release on Feb 05, 2026.

Has Astron Limited ever had a stock split?

Astron Limited had 2 splits and the recent split was on May 10, 2007.

Astron Limited Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Stephan B. Tanda CEO
CXA Exchange
US0383361039 ISIN
US Country
13,000 Employees
23 Oct 2025 Last Dividend
10 May 2007 Last Split
21 Apr 1993 IPO Date

Overview

AptarGroup, Inc. is at the forefront of designing and manufacturing innovative solutions for drug delivery, consumer product dispensing, and active material science. With a diverse portfolio aimed at meeting the needs of various markets such as pharmaceuticals, beauty, personal care, home care, and food and beverage, AptarGroup emphasizes its commitment to addressing consumer demands and industry challenges. Operating through three primary segments - Aptar Pharma, Aptar Beauty, and Aptar Closures, the company showcases a multifaceted approach to delivering excellence and innovation. Since its incorporation in 1992, AptarGroup has established a significant global presence, actively serving customers across Asia, Europe, Latin America, and North America from its headquarters in Crystal Lake, Illinois. This extensive footprint underscores its dedication to accessibility and service excellence worldwide.

Products and Services

The comprehensive range of products and services offered by AptarGroup caters to a wide array of market needs, ensuring high-quality, innovative solutions that enhance user experience and functionality. Here's a closer look at their offerings:

  • Pumps for Nasal Allergy Treatments: AptarGroup has developed specialized dispensing pumps designed for the efficient and effective delivery of medication for nasal allergy relief. These products emphasize precision, ease of use, and improved patient compliance.
  • Metered Dose Inhaler Valves: Targeted towards individuals with respiratory ailments such as asthma and chronic obstructive pulmonary diseases (COPD), these valves are a critical component in metered dose inhalers, facilitating accurate medication delivery and supporting better respiratory health management.
  • Elastomer for Injectable Primary Packaging Components: AptarGroup's elastomeric components are essential for ensuring the safety, integrity, and effectiveness of injectable medications. These high-quality components play a crucial role in the pharmaceutical packaging industry.
  • Active Material Science Solutions: Expanding beyond traditional dispensing solutions, AptarGroup is also deeply involved in offering active material science solutions. These innovations focus on enhancing product preservation, extending shelf life, and improving the overall consumer experience.
  • Dispensing Pumps, Closures, and Aerosol Valves: AptarGroup’s product range includes a variety of dispensing pumps, closures, and aerosol valves designed for the consumer goods sector. These solutions are tailored to enhance the functionality and user-friendliness of a wide range of products, from personal care items to home cleaning agents.
  • Digital Health Solutions: Recognizing the growing importance of technology in healthcare, AptarGroup offers digital health solutions that leverage the power of digital tools to enhance medication adherence, patient engagement, and overall health outcomes.

Contact Information

Address: 265 Exchange Drive
Phone: 815 477 0424